AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
Kinase |
-3.23 |
2.48E-10 |
ATF1 |
Activating transcription factor 1 |
Transcription regulator |
-9.9 |
1.23E-10 |
CCNA2 |
Cyclin A2 |
Other |
-41.76 |
1.8E-13 |
CCNB1 |
Cyclin B1 |
Other |
-181.97 |
1.74E-17 |
CCNB2 |
Cyclin B2 |
Other |
-70.13 |
1.49E-17 |
CCNE2 |
Cyclin E2 |
Other |
-48.24 |
2.76E-16 |
CDC2 |
Cell division cycle 2, G1 to S and G2 to M |
Kinase |
-32.91 |
1.49E-17 |
CDK2 |
Cyclin-dependent kinase 2 |
Kinase |
-4.15 |
4.53E-12 |
CHEK1 |
CHK1 checkpoint homolog (Schizosaccharomyces pombe) |
Kinase |
-17.77 |
2.85E-11 |
EGFR |
Epidermal growth factor receptor |
Kinase |
-5.6 |
1.66E-10 |
H2AFX |
H2A histone family, member X |
Other |
-7.56 |
3.6E-15 |
HMGB2 |
High-mobility group box 2 |
Transcription regulator |
-8.3 |
2.88E-14 |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
Enzyme |
-3.16 |
5.04E-09 |
IGFBP3 |
Insulin-like growth factor binding protein 3 |
Other |
-5.71 |
.00000303 |
IL8 |
Interleukin 8 |
Cytokine |
-8.4 |
1.97E-13 |
IL1R1 |
Interleukin 1 receptor, type I |
Transmembrane receptor |
-5.2 |
1.16E-11 |
IL1RAP |
Interleukin 1 receptor accessory protein |
Transmembrane receptor |
-18.67 |
.000848 |
IRS1 |
Insulin receptor substrate 1 |
Other |
-6.84 |
1.84E-11 |
KITLG |
KIT ligand |
Growth factor |
-4.77 |
1.03E-11 |
LMNB1 |
Lamin B1 |
Other |
-21.41 |
3.38E-15 |
MAP2K1 |
Mitogen-activated protein kinase kinase 1 |
Kinase |
-3.95 |
1.61E-11 |
MAP2K2 |
Mitogen-activated protein kinase kinase 2 |
Kinase |
-3.15 |
4.98E-08 |
MYC |
v-myc myelocytomatosis viral oncogene homolog |
Transcription regulator |
-5.59 |
5.3E-11 |
PCNA |
Proliferating cell nuclear antigen |
Other |
-5.98 |
4E-13 |
PLK1 |
Polo-like kinase 1 (Drosophila) |
Kinase |
-20.76 |
3.1E-14 |
SHC1 |
SHC (Src homolog 2 domain containing) transforming protein 1 |
Other |
-4.15 |
5.17E-12 |
TOP2A |
Topoisomerase (DNA) II alpha 170 kDa |
Enzyme |
-156.1 |
1.74E-20 |